Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

@article{Musso2011MetaanalysisNH,
  title={Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity},
  author={Giovanni Musso and R Gambino and Maurizio Cassader and Gianfranco Pagano},
  journal={Annals of Medicine},
  year={2011},
  volume={43},
  pages={617 - 649}
}
Abstract Background. NAFLD ranges from simple steatosis (SS) to non-alcoholic steatohepatitis (NASH). The natural history of NAFLD and the optimal strategy to identify subjects with progressive liver disease are unclear. Objectives. To assess the evidence in: (1) natural history of NAFLD; and (2) non-invasive methods to differentiate NAFLD histological subtypes. Design and setting. Among 4185 articles published on MEDLINE, Cochrane Library, EMBASE, Pubmed, national and International meeting… 

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis

The VAI has a predictive value in diagnosing non-alcoholic fatty liver disease and NASH, with significantly increased values in adult NAFLD patients, simple steatosis compared to controls, and severe steatotic compared to simple Steatosis.

FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis

FibroTest™ is a multi-marker panel, suggested by guidelines as one of the surrogate markers with acceptable performance for detecting fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), and showed acceptable performance only in detecting cirrhosis.

Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

This article provides a comprehensive review of the currently available and emerging non-invasive diagnostic tools used in assessing NAFLD, highlighting the importance of accurate and validated diagnostic tools.

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease

FibroMeter tests showed acceptable sensitivity and specificity in detecting advanced fibrosis in patients with non-alcoholic fatty liver disease, but an urge to conduct head-to-head comparison studies in Patients with NAFLD of the different FibroMeters remains.

Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

The hepatic ultrasound score, based on hepatic attenuation and the anteroposterior diameter of the right hepatic lobe, presented the best performance for NAFLD screening at the cutoff point ≥ 1 point.

PROGRESSION TO FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE ( NAFLD ) – THE VALUE OF NONINVASIVE MARKERS

In 14 patients fibrosis was proven histologically and it was statistically more common in patients with diabetes and AST/ALT ratio higher than 0.8; positive predictive value and negative predictive value for Fibrotest and BARD score were, 93%, 71% and 61%, 84% respectively.

Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals

A meta-analysis of relevant studies shows that non-alcoholic fatty liver disease is associated with a ~2.2-fold increased risk of incident diabetes, which parallels the underlying severity of NAFLD.
...

References

SHOWING 1-10 OF 212 REFERENCES

NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study

Subjects with NAFLD and elevated ALT levels are at an increased risk of developing diabetes and the MS, and this may be because of the presence of associated metabolic risk factors.

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

In patients with non-alcoholic fatty liver disease, NashTest, a simple and non-invasive biomarker reliably predicts the presence or absence of NASH.

Long-term follow-up of patients with nonalcoholic fatty liver.

  • Nila RafiqC. Bai Z. Younossi
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2009

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

In patients with NAFLD, FibroTest, a simple and non-invasive quantitative estimate of liver fibrosis reliably predicts advanced fibrosis.

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

An easily calculated score based on readily available clinical data can reliably exclude the presence of advanced fibrosis in patients with NAFLD, particularly among non-diabetics.

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

Normal ALT is not a valuable criterion to exclude patients from liver biopsy, and Alterations in glucose metabolism and insulin resistance in subjects with normal ALT should also be considered in the selection of NAFLD cases for histological assessment of disease severity and progression.

The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD

The low NAFLD fibrosis score demonstrated high accuracy for ruling out advanced fibrosis, with negative predictive value (NPV) of 98 and 99% in groups A and B, respectively.

Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

Both NASH and fibrosis are frequently present among patients with non-alcoholic fatty liver disease and sustained elevation of liver function tests, and the probability of these potentially progressive stages of NAFLD increases with the presence of abnormal glucose tolerance.

Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease.

Specific relationships between hepatic histology and markers of the metabolic syndrome are explored in human subjects with nonalcoholic fatty liver disease, finding that insulin resistance, even without these other features, is almost universal in subjects with NAFLD.
...